China Pharma (NYSE:CPHI) Earns Hold Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of China Pharma (NYSE:CPHI) in a report published on Monday. The firm issued a hold rating on the stock.

China Pharma Stock Performance

Shares of NYSE:CPHI opened at $0.21 on Monday. The firm’s 50 day moving average is $0.21 and its two-hundred day moving average is $0.21. China Pharma has a 52 week low of $0.13 and a 52 week high of $0.60. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.26 and a current ratio of 0.79.

China Pharma Company Profile

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.